Dr. Kintur Sanghvi, MD

Dr. Sanghvi practices at Deborah Heart and Lung Center in Browns Mills, New Jersey, part of Deborah Heart and Lung Center.

Dr. Sanghvi's NPI, 1770627200, was assigned on February 17, 2007. Dr. Sanghvi holds New Jersey license 25MA08823700.

Dr. Sanghvi's primary practice is Deborah Heart and Lung Center, at 200 Trenton Road, Browns Mills, NJ 08015 in Burlington County. The practice phone is (609) 893-6611.

Dr. Sanghvi's primary practice is Deborah Heart and Lung Center in Browns Mills, New Jersey, part of Deborah Heart and Lung Center. Dr. Sanghvi is also affiliated with Virtua Voorhees Hospital. The medical group on file is Virtua Medical Group. Dmand AI also links Dr. Sanghvi to 4 more hospitals, 2 medical groups, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sanghvi practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Sanghvi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Sanghvi's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 731 Medicare services from Dr. Sanghvi across 12 procedure codes in 2024, for 243 Medicare patients. Medicare paid $71,833 for them.

CMS counts 243 Medicare patients who saw Dr. Sanghvi in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sanghvi's median patient age at 65, with 38% women.

In 2024, Dr. Sanghvi wrote 1,357 Medicare Part D claims for 204 patients. 87% of them were for generic drugs. CMS names the drug for 1,199 of them, across 21 drugs with 11 or more claims each, at $207,467 in total drug cost. In 2023, CMS named 1,530 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Sanghvi for performance year 2024, reported as part of a group. Dr. Sanghvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 43 procedures of coronary angioplasty and stenting by Dr. Sanghvi, more than 79% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 37 papers to Dr. Sanghvi, published from 2012 to 2023. 2018 was the busiest year, with 5. The most frequent topics are Coronary Angiography, Radial Artery and Cardiac Catheterization. Dr. Sanghvi has published most often in J Invasive Cardiol. Dr. Sanghvi's most frequent co-authors are Jan Neil Basile, MD, Ajay J. Kirtane, MD and Yale Lewis Wang, MD.

Dmand AI links Dr. Sanghvi to 5 clinical trials. 4 are still active or recruiting. Conditions studied include Essential Hypertension, Hypertension and Coronary Artery Disease. ReCor Medical, Inc. sponsors the most, 2.

CMS Open Payments shows 520 general payments to Dr. Sanghvi from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Medtronic, Inc. paid the most, $78,152.